The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detailed immunogenomic analysis of high dose IL-2 pharmacodynamic effects: A benchmark for next-generation IL-2-based immunotherapies.
 
Kirk Beebe
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
 
Joel Robert Eisner
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric; Innocrin Pharma
Consulting or Advisory Role - Propella Therapeutics
Patents, Royalties, Other Intellectual Property - Provisional patents for GeneCentric and Innocrin Pharma as part of my employments
 
Yoichiro Shibata
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - Patent pending for Tumor Mutation Burden (TMB) from RNA-seq
 
James M Davison
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
 
John Guo
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
 
Carol J. Farhangfar
No Relationships to Disclose
 
Farhang Farhangfar
No Relationships to Disclose
 
Joshua M. Uronis
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - AstraZeneca (I)
Research Funding - Bristol-Myers Squibb (I); Genentech (I); Leap Therapeutics (I); Macrogenics (I); Merck (I)
 
Jill Mooney
Employment - Synthorx
Stock and Other Ownership Interests - Synthorx
 
Michael Vance Milburn
Employment - GeneCentric
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
 
David Foureau
No Relationships to Disclose
 
Richard L. White
No Relationships to Disclose
 
Asim Amin
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Exelixis (Inst); Merck (Inst)
 
Marcos E Milla
Employment - Synthorx
Leadership - Synthorx
Stock and Other Ownership Interests - Synthorx